- Published at
- by investing.com
positive
positive
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US By Investing.com
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
News for Relief Therapeutics Holding AG (RLFTF)
- Published at
- by gurufocus.com
positivepositiveRelief Therapeutics Provides Update on Potential Transaction with Renexxion
GENEVA, SWITZERLAND / ACCESSWIRE / December 27, 2024 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmace- Published at
- by gurufocus.com
positivepositiveRelief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU GOLIKE- Published at
- by investing.com
positivepositiveRelief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE By Investing.com
Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE- Published at
- by investing.com
positivepositiveRelief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents By Investing.com
Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents- Published at
- by investing.com
positivepositiveRelief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 By Investing.com
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024- Published at
- by investing.com
positivepositiveRelief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update By Investing.com
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update- Published at
- by investing.com
positivepositiveRelief Therapeutics Secures up to $11 Million from Royalty Sales By Investing.com
Relief Therapeutics Secures up to $11 Million from Royalty Sales- Published at
- by investing.com
positivepositiveRelief Therapeutics Announces Executive Changes By Investing.com
Relief Therapeutics Announces Executive Changes- Published at
- by investing.com
positivepositiveRelief Therapeutics Announces Notice of Annual General Meeting of Shareholders By Investing.com
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders- Published at
- by marketscreener.com
positivepositiveRelief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics
Relief Therapeutics Holding AG announced it has entered into a new exclusive definitive licensing agreement with Acer Therapeutics Inc. for the development and commercialization of OLPRUVA? for the...- Published at
- by marketscreener.com
positivepositiveAcer Therapeutics Gets FDA Approval for Lead Drug Candidate Olpruva
By Mary de Wet Acer Therapeutics Inc. has received approval from the Food and Drug Administration for Olpruva, the first of four drugs the company was investigating. The drug, also known... | December 23, 2022- Published at
- by seekingalpha.com
neutralneutralRelief Therapeutics Holding AG reports 1H results
Relief Therapeutics Holding AG press release (RLFTF): 1HRevenue of CHF 3.24M.Net loss for the period was CHF 26.5M, compared to a net loss of CHF 14.7M for the same period last year.- Published at
- by marketscreener.com
mixedmixedRelief Reports Half-Year 2022 Results and Provides Corporate Update
Relief Therapeutics Holding SA / Key word: Interim Report Relief Reports Half-Year 2022 Results and Provides Corporate Update 15-Sep-2022 / 07:00 CET/CEST Release of an ad hoc announcement... | September 15, 2022- Published at
- by marketscreener.com
positivepositiveRelief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
Relief Therapeutics Holding SA / Key word: Conference Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum 12.09.2022 / 07:05 CET/CEST Relief... | September 12, 2022- Published at
- by etfdailynews.com
positivepositiveRelief Therapeutics Holding AG (OTCMKTS:RLFTF) Short Interest Up 27.8% in May
Read Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Short Interest Up 27.8% in May at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveShort Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Grows By 86.2%
Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Grows By 86.2% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveShort Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Expands By 43.7%
Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Expands By 43.7% at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveShort Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Declines By 48.5%
Read Short Interest in Relief Therapeutics Holding AG (OTCMKTS:RLFTF) Declines By 48.5% at ETF Daily News- Published at
- by marketscreener.com
mixedmixedAcer Therapeutics : Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update - Form 8-K
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update NEWTON, MA - March 2, 2022 - Acer Therapeutics Inc. , a pharmaceutical company... | March 2, 2022